RDWM
HRTX icon

Red Door Wealth Management’s Heron Therapeutics HRTX Stock Holding History

Red Door Wealth Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,900
Closed -$15.1K – 329
2026
Q1 		$15.1K Buy
18,900
+8,500
+82% +$9.85K ﹤0.01% 307
2025
Q4 		$13.5K Buy
+10,400
New +$12.8K ﹤0.01% 289

Other funds holding HRTX

CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
AR
Apeiron RIA Dallas, Texas $390M AUM 22.97% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
TWM
TopTier Wealth Management Muskego, Wisconsin $166M AUM
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Red Door Wealth Management's HRTX Position: Q2 2026 in Review

Red Door Wealth Management sold out of Heron Therapeutics (HRTX) in Q2 2026, closing a stake of 18,900 shares — an estimated $15.1K sold.

Red Door Wealth Management first reported a position in HRTX in Q4 2025 and held it in 2 quarters. The position peaked at $15.1K in Q1 2026. 17 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Red Door Wealth Management reported no remaining Heron Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Red Door Wealth Management sold 18,900 Heron Therapeutics shares in Q2 2026, an estimated $15.1K.
  • Red Door Wealth Management first reported a position in Heron Therapeutics in Q4 2025 and held it in 2 quarters.
  • Red Door Wealth Management's Heron Therapeutics position peaked at $15.1K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.